Contact Us
Company Overview
|
Pipeline / Clinical Trials
|
Science & Discovery
|
Business Development
|
Investors
Overview
|
Stock Data
|
Governance
|
SEC Filings
|
News & Events
|
Presentations
|
Fundamentals
|
Information Request
Press Release Archive
Press Release Archive
2010
>
2009
>
2008
>
2007
>
2006
>
2005
>
2004
>
2003
>
2002
> 2001
December 17, 2001
RegeneRx's Tß4 Effective In Wound Repair In Aging Animals
September 19, 2001
RegeneRx's Tß4 Reported To Accelerate Healing Of Wounds And May Reduce Severity Of Septic Shock
August 30, 2001
RegeneRx Enters Into Research Agreement with U. of Texas Southwestern Medical Center
June 13, 2001
RegeneRx’s Lead Drug Targeted at $7 Billion Wound Healing Market
May 22, 2001
RegeneRx Enters Into Research & Development Agreement with National Institutes of Health
May 21, 2001
RegeneRx’s Tß4 May Repair Damage to Aging Skin
May 10, 2001
RegeneRx's Tß4 Accelerates Healing of Eye Wounds
April 11, 2001
RegeneRx Launches Web Site
March 28, 2001
RegeneRx Reports 2000 Financial Results
March 23, 2001
RegeneRx Added to OTC Bulletin Board
February 6, 2001
RegeneRx Receives Exclusive License from NIH for Novel Wound Healing Drug
home
|
Contact Us
|
Resources
|
Site Map
|
Search
